Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy

Carla Minoia; Vincenza de Fazio; Giovanni Scognamillo; Anna Scattone; Nicola Maggialetti; Cristina Ferrari; Attilio Guarini

doi:10.3390/diagnostics9030084

Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy

Carla Minoia, Vincenza de Fazio, Giovanni Scognamillo, Anna Scattone, Nicola Maggialetti, Cristina Ferrari, Attilio Guarini

Research output: Contribution to journal › Article

Abstract

Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.

Original language	English
Article number	84
Journal	Diagnostics
Volume	9
Issue number	3
DOIs	https://doi.org/10.3390/diagnostics9030084
Publication status	Published - Sep 1 2019

Fingerprint

Keywords

Acute myeloid
Breast
Decitabine
Extramedullary
Leukemia
Myeloid
Sarcoma

ASJC Scopus subject areas

Clinical Biochemistry

Cite this

Minoia, C., de Fazio, V., Scognamillo, G., Scattone, A., Maggialetti, N., Ferrari, C., & Guarini, A. (2019). Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy. Diagnostics, 9(3), [84]. https://doi.org/10.3390/diagnostics9030084

@article{2d74f2ca12aa43f6bfc08c1c2d5ea810,

title = "Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy",

abstract = "Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.",

keywords = "Acute myeloid, Breast, Decitabine, Extramedullary, Leukemia, Myeloid, Sarcoma",

author = "Carla Minoia and {de Fazio}, Vincenza and Giovanni Scognamillo and Anna Scattone and Nicola Maggialetti and Cristina Ferrari and Attilio Guarini",

year = "2019",

month = sep

day = "1",

doi = "10.3390/diagnostics9030084",

language = "English",

volume = "9",

journal = "Diagnostics",

issn = "2075-4418",

publisher = "MDPI AG",

number = "3",

}

TY - JOUR

T1 - Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy

AU - Minoia, Carla

AU - de Fazio, Vincenza

AU - Scognamillo, Giovanni

AU - Scattone, Anna

AU - Maggialetti, Nicola

AU - Ferrari, Cristina

AU - Guarini, Attilio

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.

AB - Myeloid sarcoma (MS) represents a rare disease with an adverse clinical outcome for patients not candidate to acute myeloid leukemia (AML)-like chemotherapies. Here we present the case of an elderly patient affected by a bilateral breast localization of MS treated with the hypomethylating agent decitabine associated to radiotherapy. The association of the two treatment modalities has allowed an optimal and long-lasting disease control.

KW - Acute myeloid

KW - Breast

KW - Decitabine

KW - Extramedullary

KW - Leukemia

KW - Myeloid

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85072598188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072598188&partnerID=8YFLogxK

U2 - 10.3390/diagnostics9030084

DO - 10.3390/diagnostics9030084

M3 - Article

AN - SCOPUS:85072598188

VL - 9

JO - Diagnostics

JF - Diagnostics

SN - 2075-4418

IS - 3

M1 - 84

ER -

Access to Document

10.3390/diagnostics9030084

Projects

ONCOLOGICO DI BARI - L'INTEGRAZIONE, LA MINI-INVASIVITA' E L'INNOVAZIONE TECNOLOGIA: TRATTAMENTI FISICO-CHIMICI SINGOLI, DI COMBINAZIONE, LOCO-REGIONALI E SISTEMICI

Project: Other project

Long-lasting remission in de novo breast myeloid sarcoma treated with decitabine and radiotherapy

Abstract

Fingerprint

Keywords

ASJC Scopus subject areas

Cite this

Access to Document

Related content

Projects

ONCOLOGICO DI BARI - L'INTEGRAZIONE, LA MINI-INVASIVITA' E L'INNOVAZIONE TECNOLOGIA: TRATTAMENTI FISICO-CHIMICI SINGOLI, DI COMBINAZIONE, LOCO-REGIONALI E SISTEMICI